For research use only. Not for therapeutic Use.
Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH)[1].
Aldafermin can inhibit bile acid synthesis and regulates metabolic homeostasis[1].
| Catalog Number | I042181 |
| CAS Number | 1616639-03-2 |
| Purity | ≥95% |
| Reference | [1]. Stephen A Harrison, et al. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. Gastroenterology. 2021 Jan;160(1):219-231.e1. |
